Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for non-exclusive discount agreements for the drug Aflibercept in Germany, issued by AOK PLUS - The Health Insurance Fund for Saxony and Thuringia. The contract will be established under an Open-House model, allowing participation until December 31, 2027.
Scope Of Work: This tender involves the establishment of non-exclusive discount agreements for Aflibercept injectable solution, as per § 130a Abs. 8 SGB V. The agreements will be available to all interested pharmaceutical companies that meet participation requirements. The quantities required are unknown and will depend on demand and other factors, with no minimum purchase guarantees. Interested firms must apply for access to the project room on the German Procurement Portal (DTVP) to obtain participation documents, which are subject to confidentiality. The submission of participation requests begins on December 2, 2026, and the agreements will end by December 31, 2027.
Qualification Criterion: Bidder eligibility includes compliance with the participation requirements set out in the project documents available on the DTVP. Interested pharmaceutical companies must apply for access to the project room and adhere to confidentiality regarding the contents of the participation documents. Specific mandatory submissions and technical requirements are detailed in the documents provided in the project room. Late submissions will be considered in the next submission period, and all documents must be securely destroyed if participation is not pursued.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Operation of a Dynamic Procurement System for Laboratory Consumables. | Germany | 152653979 | 02 Jan 2027 |
| Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 | Germany | 152653877 | 10 Aug 2028 |
| Open House Biologics Discount Agreements 2026-09 - Etanercept | Germany | 152653671 | 31 Dec 2026 |
| Delivery of Cleaning Products, Anker Facilities, Gu Etc., Government of Lower Bavaria | Germany | 152653374 | 17 Dec 2026 |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Tacrolimus (Atc: D11ah01). | Germany | 152653349 | 27 Oct 2028 |